Drug companies are set to increase prices on over 350 medicines. This includes vital vaccines and cancer drugs. The median price hike is ar...

The third quarter earnings results will be announced by 134 companies, with key players such as Nestle India, IndusInd Bank, Sun Pharma, ON...

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning January 1, 2025.

All three main stock indexes climbed more than 1% shortly after the opening bell, in part due to an easing in Treasury yields, and all thre...

The U.S. dollar reached its strongest level in more than a month against the Japanese yen on Tuesday, lifted by a jump in Treasury yields o...

As recently as Oct. 20, markets were pricing rate cuts of up to 25 basis points from leading central banks by next autumn as the resurgent ...

Pfizer has already announced plans to hike prices on 41 of its drugs in mid-January.

The Competition and Markets Authority (CMA) also fined Flynn Pharma 5.2 million pounds for overcharging for phenytoin sodium capsules, foll...

The FM explained that the move would not only enhance vaccine security, but also insulate vaccine prices from arbitrary escalation.

Pfizer today allayed concerns that acquisition of Indian pharmaceutical firms by multinationals will lead to an increase in drug prices.

The finance ministry is understood to be also considering hiking the weighted deduction on expenditure on R&D) by drug companies to 200% fr...

Drug price regulator National Pharmaceutical Pricing Authority allows cos to up MRP of popular insulin brands by 15%.

Investors could see some good arbitrage opportunities, as foreign parents of many MNCs are expected to hike their holdings in Indian subsid...

Pfizer has revised its open offer price for shares of its Indian subsidiary Pfizer India by almost 23% from Rs 675 to Rs 830 per share. As ...

The country’s top drug price regulator has reworked the prices of 184 bulk drugs, thus making 77 medicines more affordable, and brought in ...

Financial institutions led by the LIC are objecting to US pharma major Pfizer Inc's open offer to increase stake in its Indian arm from 41%...